Saphetor Company
Saphetor is a precision medicine company that specializes in genome-scale analysis using Next Generation Sequencing (NGS). Their suite of services offers clinicians data-driven solutions for faster and more accurate diagnoses, particularly for cancer and difficult-to-diagnose conditions like rare diseases or cognitive impairment. Their VarSome Suite is a set of AI-driven tools for large-scale NGS data analysis, with VarSome.com being a freely available community-driven project and VarSome.com Premium and VarSome Clinical being professional extensions for researchers and clinicians.
.png)
Founded Date:
2014
Last Funding Type:
Series A
Headquarters:
Lausanne, Vaud
Investors Number:
4
Technology:
NextGen sequencing analysis
Employee Number:
51-100
Industry:
Preclinical/Clinical Trials (CRO)
Estimated Revenue:
Less than $1M
Funding Status:
Early Stage Venture
Investor Type:
For Profit
Total Funding:
CHF6.4M